Skip to content

A clinical trial to study effect of Gravity aided cord blood transfusion vs standard care on hemoglobin at 48 hours of life in late preterm and term neonates delivered via LSCS

Effect of Gravity aided cord blood transfusion vs standard care on Hemoglobin at 48 Hours of life in Late Preterm and Term Neonates delivered via LSCS: A Randomized non inferiority Controlled Trial - GCT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045195
Enrollment
200
Registered
2022-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Mamta Hareshbhai Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: infants born at 34 0/7 week - 41 6/7 week gestational age via LSCS

Exclusion criteria

Exclusion criteria: Multiple gestation Major congenital and chromosomal anomalies Hydrops fetalis Rh isoimmunization (Mother ICT Positive) True umbilical cord knots Cord prolapse Placental abruption

Design outcomes

Primary

MeasureTime frame
Hemoglobin levelTimepoint: at 48 hrs of life

Secondary

MeasureTime frame
Hematocrit levelTimepoint: at 48 hrs of life;Hemoglobin levelTimepoint: at 6 weeks;Incidence of exchange transfusionTimepoint: during first 2 weeks of life;Incidence of hyperbilirubinemia requiring phototherapyTimepoint: during first 2 weeks of life;Serum ferritin levelTimepoint: at 6 weeks;temperature at the time of receiving at the warmerTimepoint: after birth;Total serum bilirubin levelTimepoint: at 48 hrs of life

Countries

India

Contacts

Public ContactMamta Hareshbhai Patel

SRMC

drumarajakumar@gmail.com9941853855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026